[go: up one dir, main page]

AR002104A1 - Agentes antifungicos de peptidos ciclicos. - Google Patents

Agentes antifungicos de peptidos ciclicos.

Info

Publication number
AR002104A1
AR002104A1 ARP960102722A AR10272296A AR002104A1 AR 002104 A1 AR002104 A1 AR 002104A1 AR P960102722 A ARP960102722 A AR P960102722A AR 10272296 A AR10272296 A AR 10272296A AR 002104 A1 AR002104 A1 AR 002104A1
Authority
AR
Argentina
Prior art keywords
antifungal agents
cyclic peptide
alkyl
peptide antifungal
alkoxy
Prior art date
Application number
ARP960102722A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR002104A1 publication Critical patent/AR002104A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan formulaciones farmacéuticas y procedimientos para inhibir la actividad fúngica y parasitaria, usando un compuesto de fórmula (I), en laque R2 es (II), cada R2a es, independientemente, hidroxi, halo, nitro, amino, trifluormetilo, alquilo C1-C6, alcoxi C1-C6 o alquiltio C1-C6; a es 1, 2, 3 ó4; R3 es alquilo C1-C12, alcoxi C1-C12 u -O-(CH2)m-[O-(CH2)n]p-O-(alquilo C1-C12); m es 2, 3 ó 4; n es 2, 3 ó 4; y p es 0 ó 1; o una salfarmacéuticamente aceptable de los mismos.
ARP960102722A 1995-05-26 1996-05-24 Agentes antifungicos de peptidos ciclicos. AR002104A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45133795A 1995-05-26 1995-05-26

Publications (1)

Publication Number Publication Date
AR002104A1 true AR002104A1 (es) 1998-01-07

Family

ID=23791818

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102722A AR002104A1 (es) 1995-05-26 1996-05-24 Agentes antifungicos de peptidos ciclicos.

Country Status (11)

Country Link
US (1) US5786325A (es)
EP (1) EP0744407B1 (es)
AR (1) AR002104A1 (es)
AT (1) ATE225804T1 (es)
AU (1) AU5799096A (es)
DE (1) DE69624167T2 (es)
ES (1) ES2180699T3 (es)
IL (1) IL118331A0 (es)
PE (1) PE37897A1 (es)
WO (1) WO1996037509A1 (es)
ZA (1) ZA964011B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
WO1999006062A1 (en) * 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (en) 1998-08-20 2005-01-26 Eli Lilly & Company Synthesis of ring-modified cyclic peptide analogs
IL143563A0 (en) 1998-12-09 2002-04-21 Lilly Co Eli Purification of echinocandin cyclopeptide compounds
KR20020002476A (ko) 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
WO2000052037A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin/carbohydrate complexes
WO2000051564A1 (en) * 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
BR0008713A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Processos para preparar formulações ecomposições farmacêuticas orais com ecb
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
EP1390081A2 (en) 2001-01-08 2004-02-25 Neorx Corporation Therapeutic and diagnostic compounds, compositions, and methods
JP2005516933A (ja) 2001-12-13 2005-06-09 ダウ グローバル テクノロジーズ インコーポレイティド 放射性医薬による骨髄炎の治療
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
EA200501713A1 (ru) * 2003-04-30 2006-06-30 ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи Фенилзамещённые карбоновые кислоты
US10825328B2 (en) 2017-07-03 2020-11-03 Motorola Solutions, Inc. Apparatus for managing a plurality of devices in a portable communication system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
IE912046A1 (en) * 1990-06-18 1991-12-18 Fujisawa Pharmaceutical Co New polypeptide compound and a process for preparation¹thereof
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5233023A (en) * 1991-07-30 1993-08-03 Merck & Co., Inc. Process for phosphate ester compounds of certain cyclohexapeptides
IL122315A (en) * 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
WO1994025045A1 (en) * 1993-05-04 1994-11-10 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5541160A (en) * 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
EP0744407A2 (en) 1996-11-27
DE69624167T2 (de) 2003-02-13
ATE225804T1 (de) 2002-10-15
IL118331A0 (en) 1996-09-12
ZA964011B (en) 1997-11-20
WO1996037509A1 (en) 1996-11-28
ES2180699T3 (es) 2003-02-16
PE37897A1 (es) 1997-10-09
DE69624167D1 (de) 2002-11-14
US5786325A (en) 1998-07-28
EP0744407A3 (en) 1998-05-20
EP0744407B1 (en) 2002-10-09
AU5799096A (en) 1996-12-11

Similar Documents

Publication Publication Date Title
AR002104A1 (es) Agentes antifungicos de peptidos ciclicos.
EP0744405A3 (en) Cyclic peptide antifungal agents
PT561639E (pt) Agentes antifungicos de peptido ciclico e processos para a sua preparacao
GEP19991870B (en) Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists
EA199700307A1 (ru) Циклические пептидные антигрибковые агенты
EP0638567A4 (en) ADENOSINE INHIBITORS.
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
FI860878A0 (fi) Aminosyraderivat och foerfarande foer deras framstaellning.
PE38297A1 (es) Agentes antifungicos de peptidos ciclicos
BR0314844A (pt) Novo composto
DK0757058T3 (da) Cykliske peptider som anti-fungale midler
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
OA09119A (fr) Nouveaux céphèmes et leur préparation.
ES2179523T3 (es) Metodo para aumentar la biodisponibilidad de la fexofenadina y sus derivados.
NZ302072A (en) 1,3-diamino propyl stereomeric derivatives and organic acid and inorganic salts of their amine intermediates in the preparation of retroviral protease inhibitors
DK0399519T3 (da) Potensering af celleformidlet immunitet under anvendelse af polyaminderivater
EP0744404A3 (en) Cyclic peptide antifungal agents
ATE247108T1 (de) Antifungale tetrahydrofurane
SE9603285D0 (sv) New compounds
NO985186D0 (no) Forbindelser med camptothecin-grunnstruktur, isolert fra Mappia foetida, og anvendelse derav som syntoner for nye legemidler samt som terapeutiske midler
WO2000078793A3 (en) Antimicrobial agents
EP1245228A3 (en) Medicament for the inducement of cognition enhancement
DK0823254T3 (da) Hidtil ukendt anvendelse af pyrazolopyridinforbindelser
ECSP961755A (es) Agentes antifungicos de peptidos ciclicos (caso x-9249)
DE69205383D1 (de) N,N',N'-trisubstituierte 5-Bisaminomethylen-1,3-Dioxan-4,6-Dione als Acyl-CoA: Cholesterol-Acyltransferasehemmer.